12 April 2011

Walgreens Vice President of Clinical Affairs Examines Impact of Growing Specialty Pharmacy Industry at Pinsonault Associates Managed Markets Summit

DEERFIELD, Ill., April 12, 2011 - Walgreens (NYSE:WAG) (NASDAQ:WAG) Vice President of Clinical Affairs Dr. David Lorber discussed key trends in specialty pharmacy today at the Pinsonault Associates Managed Markets Summit in Miami. The session, titled “Employer Issues in Specialty Pharmacy,” examined the impact for payers, including the role of adherence in cost management and containment, benefit and coverage decisions, formulary and medical policy, pipeline management, provider network and member satisfaction and disruption.